Source-linked briefing Health

Trials Explore Metformin, Exercise and GLP-1 Drugs to Curb Obesity-Linked Lung Cancer Risk

Trials Explore Metformin, Exercise and GLP-1 Drugs to Curb Obesity-Linked Lung Cancer Risk

New research is testing whether metformin, physical activity, and GLP-1 medications can reduce lung cancer risks driven by obesity. Investigators report ongoing trials and emerging human data aimed at expanding preventive strategies.

Original headline

Expanding the Evidence on Lung Cancer Prevention

Be the source

Share your story

A link, a project or a professional achievement can be the start of a Spotlight story.

Sign in with QAuth